Eyenovia Stock News

NEW YORK, June 09, 2022 (GLOBE NEWSWIRE) -- Eyenovia, Inc. (NASDAQ: EYEN), an ophthalmic pharmaceutical technology company developing a pipeline of microdose array print (MAP™) investigational produ

NEW YORK, June 09, 2022 (GLOBE NEWSWIRE) -- Eyenovia, Inc. (NASDAQ: EYEN), an ophthalmic pharmaceutical technology company developing a pipeline of microdose array print (MAP™) investigational produ

Eyenovia, Inc. (NASDAQ:EYEN ) Q1 2022 Earnings Conference Call May 12, 2022 4:30 PM ET Company Participants Eric Ribner - Investor Relations Sean Ianchulev - President, Chief Executive Officer & Chief

Presentation to review historic issues related to glaucoma therapies and how these may be addressed through the use of Optejet® technology Presentation to review historic issues related to glaucoma t

Eyenovia, Inc. (EYEN) CEO Sean Ianchulev on Q4 2021 Results - Earnings Call Transcript

Eyenovia Inc (NASDAQ: EYEN ) has entered into a Securities Purchase Agreement with Armistice Capital Master Fund Ltd for gross proceeds of $15 million . The offering includes 3 million shares, pre-funded warrants to purchase up to 1.87 million shares, and common warrants to purchase up to 4.87 million shares. The aggregate offering price for each share of … Full story available on Benzinga.com

Eyenovia (EYEN) trades 2.3% down premarket after it entered into a securities purchase agreement with Armistice Capital Master Fund in an offering of 3M shares of its common…

I will share a status report on events since my original article. I will give my readers a rationale of what happened to cause the CRL delay with the FDA decision. New information and an updated timel

Eyenovia <> completed a Type A meeting with the U.S. Food and Drug Administration ((FDA)) related to a refiling of the new drug application for MydCombi

Penny stocks to buy now according to insiders. The post 8 Penny Stocks To Buy Now According To Insiders In 2022 appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.

Eyenovia, Inc. (NASDAQ:EYEN) major shareholder Stuart M. Grant purchased 100,000 shares of the firms stock in a transaction that occurred on Wednesday, December 15th. The shares were acquired at an average price of $3.45 per share, with a total value of $345,000.00. The acquisition was disclosed in a filing with the SEC, which is accessible []

Eyenovia, Inc. (NASDAQ:EYEN) major shareholder Stuart M. Grant bought 100,000 shares of the business’s stock in a transaction dated Wednesday, December 15th. The stock was purchased at an average price of $3.45 per share, with a total value of $345,000.00. The transaction was disclosed in a document filed with the SEC, which can be accessed […]

Eyenovia, Inc.'s (EYEN) CEO Dr. Sean Ianchulev on Q3 2021 Results - Earnings Call Transcript

Eyenovia, Inc. (EYEN) delivered earnings and revenue surprises of 11.54% and -100.00%, respectively, for the quarter ended September 2021. Do the numbers hold clues to what lies ahead for the stock?